Hormone Replacement Therapy for Women — Beyond Hot Flashes and Into Longevity

The conversation around hormone therapy for women has been distorted by fear for over two decades. The 2002 Women’s Health Initiative (WHI) study — which used synthetic conjugated equine estrogens and medroxyprogesterone acetate in women who were, on average, 63 years old and more than a decade past menopause — was reported as proof that HRT causes cancer and heart disease.

That interpretation was wrong. And the 20 years of hormone avoidance it created may be one of the greatest public health disservices in modern medicine.

The subsequent reanalysis of the WHI data, along with the Danish Osteoporosis Prevention Study, the ELITE trial, and the Kronos Early Estrogen Prevention Study (KEEPS), have consistently demonstrated that hormone therapy initiated within 10 years of menopause — using bioidentical hormones via transdermal delivery — is associated with reduced cardiovascular disease, preserved bone density, improved cognitive function, reduced all-cause mortality, and dramatically improved quality of life.

Hormones aren’t optional. They’re the operating system. And when they decline, everything downstream suffers.

The Timeline Most Women Don’t Know About

Menopause gets all the attention, but the decline begins years earlier. Perimenopause — the transition period — can start in a woman’s mid-30s and last a decade or more. During this window, progesterone declines first (causing cycle irregularity, anxiety, insomnia, and PMS amplification), followed by fluctuating and eventually declining estradiol, and a gradual reduction in testosterone and DHEA.

By the time hot flashes arrive, you’ve already lost significant hormonal support for your bones, brain, heart, muscles, and mood. Waiting for menopause to “officially” diagnose and treat is like waiting for the engine to seize before checking the oil.

What We Test

At Longitude Life, every female patient receives a comprehensive hormone panel as part of their DECODE diagnostics:

Reproductive Hormones: Estradiol, Progesterone, Total and Free Testosterone, SHBG, DHEA-S, Pregnenolone

Pituitary: LH, FSH, Prolactin

Thyroid (Complete): TSH, Free T3, Free T4, Reverse T3, Thyroid Antibodies (TPO, Thyroglobulin)

Metabolic: Fasting Insulin, HOMA-IR, HbA1c, hsCRP, Comprehensive Metabolic Panel, Advanced Lipid Panel

Additional: Cortisol (AM), Vitamin D, B12, Ferritin, Iron/TIBC, CBC

We test based on where you are in your cycle (if still cycling) and adjust interpretation accordingly. This isn’t a single progesterone draw on a random day — it’s a systematic evaluation of your entire hormonal architecture.

How We Treat

Estrogen — Transdermal Bioidentical EstradiolWe use bioidentical estradiol exclusively — never synthetic conjugated estrogens. Transdermal delivery (patch or topical cream) is our preferred route because it avoids first-pass liver metabolism, doesn’t increase clotting factor production (the primary cardiovascular risk associated with oral estrogen), and provides steady-state levels.

Dosing is individualized based on symptoms and serum levels, not a one-size-fits-all prescription.

Progesterone — Oral Micronized BioidenticalEvery woman with a uterus receiving estrogen therapy needs progesterone for endometrial protection. We use oral micronized progesterone (bioidentical) — not medroxyprogesterone acetate (the synthetic progestin used in the WHI that drove the cancer signal).

Micronized progesterone also has meaningful benefits beyond endometrial protection: it’s a neurosteroid that supports GABA receptor activity, improving sleep quality and reducing anxiety. Dosing is cyclical or continuous depending on menstrual status and clinical picture.

Testosterone — Low-Dose Compounded CreamTestosterone isn’t just a male hormone. Women produce it (in smaller quantities) and need it for libido, energy, muscle maintenance, bone density, and cognitive sharpness. Levels decline steadily from the late 20s onward.

We prescribe low-dose compounded testosterone cream, carefully titrated to support these functions without virilizing side effects. Monitoring includes free testosterone, total testosterone, and SHBG at every reassessment.

DHEA & PregnenoloneBoth are adrenal precursor hormones that decline with age. DHEA supports immune function, bone density, and mood. Pregnenolone is a neurosteroid precursor with cognitive benefits. Supplementation is based on serum levels.

Thyroid OptimizationThyroid dysfunction is disproportionately common in women, and subclinical hypothyroidism is frequently missed when only TSH is tested. We run the full panel (TSH, Free T3, Free T4, Reverse T3, antibodies) and treat with T3/T4 combination therapy when indicated — not just levothyroxine monotherapy.

Peptide Synergies for Women

Several peptides complement female hormone therapy:

PT-141 for sexual health — a melanocortin receptor agonist that works centrally to improve desire and arousal. Effective for women experiencing low libido even after hormone optimization.

CJC-1295/Ipamorelin for body composition, recovery, and skin quality via growth hormone optimization.

BPC-157 for gut health and tissue repair — particularly relevant for women with concurrent GI issues or joint pain.

Special Considerations

Perimenopause (Still Cycling): Progesterone often needs to be addressed first — cyclical dosing in the luteal phase can dramatically improve sleep, mood, and cycle regularity before estrogen therapy is indicated.

Post-Menopause: Full BHRT protocol with estradiol, progesterone, and testosterone. Earlier initiation (within the first 10 years) is associated with the strongest cardiovascular and cognitive protective effects.

Surgical Menopause: Women who have had oophorectomy experience an immediate and total loss of ovarian hormones. This requires prompt, comprehensive replacement to prevent accelerated bone loss, cardiovascular risk, and cognitive decline.

Breast Health: We take breast cancer risk seriously. We screen family history, consider genetic risk factors, and monitor appropriately. The data on bioidentical estradiol plus micronized progesterone shows a significantly different risk profile than the synthetic hormones used in the WHI. We discuss this openly with every patient.

The 90-Day Reassessment

As with every protocol at Longitude Life, your hormone therapy is never set-and-forget. Labs are re-run at 6 weeks after initiation, then every 90 days. We track symptoms, serum levels, metabolic markers, and body composition. Doses are adjusted based on data. This is the SUSTAIN pillar — your protocol evolves because your biology does.

Both the Precision Protocol ($499/month) and the Longitude Protocol ($899/month) include comprehensive female hormone management, with medications dispensed from our in-house formulary and covered by your monthly medication credit.

Your hormones are the operating system. When they decline, everything declines. We restore the foundation. → Schedule Your Hormone Evaluation